The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue

CBM 588 treatment modulated the gut microbiota composition under dysbiosis due to the use of an antimicrobial with strong activity against anaerobes and significantly reduced epithelial damage.